Back
ProShares Nasdaq-100 Dorsey Wright Momentum ETF Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison
Buy
71
QQQA
ProShares Nasdaq-100 Dorsey Wright Momentum ETF
Last Price:
$50.52
Seasonality Move:
6.33%
Buy
54
BMRN
BioMarin Pharmaceutical, Inc.
Last Price:
$61.19
Seasonality Move:
5.52%
Buy
71
ProShares Nasdaq-100 Dorsey Wright Momentum ETF (QQQA)
is a Buy
Is ProShares Nasdaq-100 Dorsey Wright Momentum ETF a Buy, Sell or Hold?
-
The current ProShares Nasdaq-100 Dorsey Wright Momentum ETF [QQQA] share price is $50.35. The Score for QQQA is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
QQQA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN)
is a Buy
Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QQQA Stock Price Chart
What is ProShares Nasdaq-100 Dorsey Wright Momentum ETF's stock price today?
-
The ProShares Nasdaq-100 Dorsey Wright Momentum ETF share price today is $50.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QQQA is experiencing slight selling pressure.
BMRN Stock Price Chart
What is BioMarin Pharmaceutical, Inc.'s stock price today?
-
The BioMarin Pharmaceutical, Inc. share price today is $61.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.
QQQA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.29 | Buy |
| Relative Strength Index (14 RSI): | 58.23 | Buy |
| Chaikin Money Flow: | -293 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.69 - 50.07) | Buy |
| Bollinger Bands (100): | (45.17 - 49.23) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 73.39 | Buy |
| Chaikin Money Flow: | 7836963 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.19 - 56.01) | Buy |
| Bollinger Bands (100): | (52.65 - 57.43) | Buy |
QQQA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.73 | Buy |
| 20-day SMA: | 48.85 | Buy |
| 50-day SMA: | 48.7 | Buy |
| 200-day SMA: | 44.97 | Buy |
| 8-day EMA: | 26.17 | Buy |
| 20-day EMA: | 12.79 | Buy |
| 50-day EMA: | 5.57 | Buy |
| 200-day EMA: | 1.46 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.6 | Buy |
| 20-day SMA: | 54.21 | Buy |
| 50-day SMA: | 53.61 | Buy |
| 200-day SMA: | 57.94 | Buy |
| 8-day EMA: | 54.44 | Buy |
| 20-day EMA: | 53.99 | Buy |
| 50-day EMA: | 54.1 | Buy |
| 200-day EMA: | 58.28 | Buy |
ProShares Nasdaq-100 Dorsey Wright Momentum ETF Earnings Growth & QQQA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.
ProShares Nasdaq-100 Dorsey Wright Momentum ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioMarin Pharmaceutical, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||